A novel and potent MICA/B antibody is therapeutically effective in KRAS LKB1 mutant lung cancer models
Ryan R Kowash, Manoj Kumar Sabnani, Laura T. Gray, Qing Deng, Nusrat U A Saleh, Luc Girard, Yujiro Naito, Kentaro Masahiro, John Dorrance Minna, David E. Gerber, Shohei Koyama, Zhiqian Lucy Liu, Hemanta Baruah, Esra A. Akbay
This paper develops a novel MICA/B-targeting antibody that enhances NK cell activity and shows therapeutic efficacy in KRAS LKB1 mutant lung cancer models.
Journal for ImmunoTherapy of Cancer · Jan 1, 2025Peer-reviewedImmunology